Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Coagulation Factor VIII

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2NovoEight

    02 1of which Novoeight

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : NovoEight

    Human Coagulation factor VIII

    arrow
    Organic Process R&D
    Not Confirmed

    Brand Name : NovoEight

    Denmark
    arrow
    Organic Process R&D
    Not Confirmed

    Novo Nordisk

    Human Coagulation factor VIII

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 238

    2019 Revenue in Millions : 248

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : of which Novoeight

    Human Coagulation factor VIII

    arrow
    PREP
    Not Confirmed

    Brand Name : of which Novoeight

    Denmark
    arrow
    PREP
    Not Confirmed

    Novo Nordisk

    Human Coagulation factor VIII

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 203

    2017 Revenue in Millions : 165

    Growth (%) : 23%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : NovoEight

    Human Coagulation factor VIII

    arrow
    PREP
    Not Confirmed

    Brand Name : NovoEight

    Denmark
    arrow
    PREP
    Not Confirmed

    Novo Nordisk

    Human Coagulation factor VIII

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 229

    2018 Revenue in Millions : 203

    Growth (%) : 13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF